La Jolla Village, California
< 15 mi
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Interventional • Run by AbbVie
Chronic Lymphocytic Leukemia (CLL)